Insider · CIK 0001457289
Paul Lammers
Files at DCOY (Salarius Pharmaceuticals, Inc.). First filing -, latest -.
Paul Lammers files SEC Form 4 as director at DCOY (Salarius Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Paul Lammers has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | DCOY Salarius Pharmaceuticals, Inc. | AGrant or award Common Stock | +2,000 | $0.00 | $0 | 2,001 | 41 d ago |
Questions about Paul Lammers
Answered from the filings on this page, as of the latest one.
Is Paul Lammers buying or selling?
Paul Lammers has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Paul Lammers's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Paul Lammers has 0.
Where does Paul Lammers file Form 4?
Paul Lammers has filed Form 4 at DCOY (Salarius Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.